Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling

Back

ESC Premium Access

Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling

Session: Frontiers in prognostic research in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor Y. Shimada (New York, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Yuichi J Shimada

Columbia University Medical Centre, New York (United States of America)

0 follower

4 more presentations in this session

Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes in over 200,000 adults

Speaker: Doctor A. de Marvao (London, GB)

Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy

Speaker: Doctor A. Cleary (London, GB)

Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy

Speaker: Doctor C. Fumagalli (Florence, IT)

Does age influence follow-up after alcohol septal ablation in hypertrophic obstructive cardiomyopathy?

Speaker: Doctor A. Batzner (Wurzburg, DE)

Access the full session

Frontiers in prognostic research in hypertrophic cardiomyopathy

Speakers: Doctor Y. Shimada, Doctor A. de Marvao, Doctor A. Cleary, Doctor C. Fumagalli, Doctor A. Batzner

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources